Drug Overview: Singulair
February 2018 •
16 pages •
Report ID: 5391448 •
Drug Overview Singulair (montelukast; Merck&Co/Kyorin) is an oral leukotriene D4 receptor antagonist used for prophylactic treatment of asthma. The drug is available in several oral formulations and is primarily taken as an add-on therapy for patients with refractory and/or allergic asthma.
The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.
Director of Corporate Development Chugach Alaska Corporation
My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.
Executive Vice President Oral Business at Skyepharma
The research specialist was very helpful, and proposed the best content for my needs.
ReportBuyer also offered a great follow-up, thanks for everything !
EMEA Managing Director
We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.
We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.
I was impressed by the customer service: it was fast, responsive, and 100% professional !
Market Research Analyst
The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.
Senior Business Development Manager